首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1824228

次世代定序市場 - 預測 2025-2030

Next Generation Sequencing Market - Forecasts from 2025 to 2030

出版日期: 2025年08月23日 | 出版商:

Knowledge Sourcing Intelligence | 英文 165 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

次世代定序市場規模：

預計次世代定序市場將從 2025 年的 166.96 億美元成長到 2030 年的 367.78 億美元，複合年成長率為 17.11%。

次世代定序(NGS) 是一項革命性的平行定序技術，具有卓越的擴充性、速度和超高通量能力。這項尖端技術能夠測定完整基因組或 RNA 或 DNA 目標區域的核苷酸序列，從根本上推動生物科學的現代化，使實驗室能夠在多個層面研究生物系統並進行多樣化的應用。

技術能力和優勢

NGS 為複雜的基因組研究提供了全面的解決方案，突破了傳統 DNA 定序技術的限制。此技術能夠實現快速全基因組定序、標靶區域深度定序、用於發現新型 RNA 變異和剪接位點的 RNA 定序 (RNA-Seq)，以及用於基因表現分析的 mRNA 定量。這些功能使 NGS 成為解決超越傳統定序方法能力的高階基因組學問題的重要工具。

NGS平台的演進帶來了高效、可攜式且方便用戶使用的系統，能夠快速提供準確的結果。這些技術改進提高了可訪問性和操作效率，促進了其在研究和臨床應用中的廣泛應用。

市場成長動力

擴大應用範圍

NGS 在各研究領域的應用日益廣泛，推動著市場需求的持續成長。基因組圖譜計畫的加強和合作研究夥伴關係關係的建立，帶來了大量的研發投入，為市場擴張奠定了堅實的基礎。 NGS 技術的多功能性使其能夠應用於從基礎研究到臨床診斷的多個生物研究領域。

政府和私人投資

政府和私營部門對研發項目的大量投資正在支撐市場成長，尤其是在新興經濟體，這些國家高度重視基因研究和疾病認知的進步。政府機構正在積極參與測序項目，以尋找癌症和其他疾病的改進治療方法。此類支援有利於新參與企業進入市場，並為現有參與企業創造成長機會。

廣泛的政府和私人支援正在推動 NGS 設備的採用，擴大必要耗材的取得管道，並支持多個地區的整體市場發展。

技術平台進步

持續的技術進步正在推動更有效率、可攜式、更便利的NGS平台的開發。這些進步正在推動整個產業的研發舉措，同時也為主要企業提供了競爭優勢。方便用戶使用、準確性和速度更高的系統的推出正在擴大潛在的用戶群和應用程式場景。

市場限制與挑戰

技術人員有限

合格專業人員的短缺是市場的主要限制因素。能夠解讀複雜NGS數據的技術人員數量有限，阻礙了研究進展和產業發展。這種技能差距尤其影響開發中國家的技術專長較為匱乏，阻礙了該技術的採用和有效使用。

研發經費挑戰

研發資金限制對市場發展構成持續挑戰，尤其是在新興經濟體。許多研究機構和學術組織面臨預算限制，無法購買先進且昂貴的NGS設備和技術。這種對外部資金的依賴帶來了不確定性，並可能限制資源受限地區的市場擴張。

解釋 NGS 平台產生的複雜數據需要專業知識和大量時間投入，這會帶來操作挑戰，從而減緩研究進度和技術採用率。

戰略意義

在應用擴展、政府支持和技術進步的推動下，NGS市場展現出強勁的成長潛力。然而，要想取得成功，必須透過全面的培訓計畫和技術簡化措施來解決技術人才的不足。市場參與企業必須在先進能力建設與可近性之間取得平衡，以最大限度地涵蓋不同的研究環境和地理區域，同時幫助培養本地專業知識和基礎設施。

本報告的主要優點

深刻分析：獲得深入的市場洞察，重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場，涵蓋主要地區和新興地區。
競爭格局：了解主要企業所採用的策略策略，並了解採用正確策略的市場滲透潛力。
市場促進因素和未來趨勢：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
可行的建議：利用洞察力來制定策略決策，在動態環境中開闢新的業務流和收益。
受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業來說，既有利又划算。

它有什麼用途？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

分析範圍

歷史資料（2022-2024）和預測資料（2025-2030）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按部門和地區（國家）分類的收益成長和預測分析
公司概況（策略、產品、財務資訊、主要趨勢等）

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
南美洲
- 巴西
- 阿根廷
- 其他
歐洲
- 德國
- 法國
- 英國
- 西班牙
- 其他
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 其他
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 印尼
- 泰國
- 台灣
- 其他

第11章競爭格局及分析

主要企業和策略分析
市佔率分析
企業合併、協議、商業合作
競爭對手儀表板

第12章：公司簡介

F. Hoffmann-La Roche AG
Agilent Technologies
Illumina, Inc.
Thermo Fisher Scientific.
Macrogen, Inc
BGI Group
Qiagen
DNASTAR
Pacific Biosciences of California, Inc.
Bio-Rad Laboratories, Inc.

第13章附錄

貨幣
先決條件
基準年和預測年時間表
相關人員的主要利益
分析方法
簡稱

圖表列表

表格列表

簡介目錄

Product Code: KSI061610956

Next Generation Sequencing Market Size:

The next generation sequencing market is expected to grow from USD 16.696 billion in 2025 to USD 36.778 billion in 2030, at a CAGR of 17.11%.

Next-generation sequencing (NGS) represents a transformative parallel sequencing technology that delivers exceptional scalability, speed, and ultra-high throughput capabilities. This advanced technology determines nucleotide sequences in complete genomes or targeted regions of RNA or DNA, fundamentally modernizing biological sciences and enabling laboratories to conduct diverse applications while studying biological systems across multiple levels.

Technology Capabilities and Advantages

NGS addresses the limitations of traditional DNA sequencing technologies by providing comprehensive solutions for complex genomics research. The technology enables rapid whole genome sequencing, deep sequencing of targeted regions, RNA sequencing (RNA-Seq) for discovering novel RNA variants and splice sites, and mRNA quantification for gene expression analysis. These capabilities position NGS as an essential tool for addressing advanced genomics questions that exceed the capacity of conventional sequencing methods.

The evolution of NGS platforms has introduced efficient, portable, and user-friendly systems capable of delivering rapid and accurate results. These technological improvements have enhanced accessibility and operational efficiency, contributing to widespread adoption across research and clinical applications.

Market Growth Drivers

Expanding Application Scope

The increasing application of NGS across diverse research areas drives sustained market demand. Enhanced genome mapping programs and collaborative partnerships result in significant R&D investments, creating a robust foundation for market expansion. The versatility of NGS technology enables its deployment across multiple biological research domains, from basic research to clinical diagnostics.

Government and Private Sector Investment

Substantial investments from both government and private sectors in research and development programs support market growth, particularly in developing countries focused on advancing genetic research and disease understanding. Government organizations actively participate in sequencing programs to identify improved treatment approaches for cancer and other diseases. This support facilitates market entry for new participants and creates growth opportunities for established industry players.

The widespread governmental and private backing has led to increased adoption of NGS instruments and expanded utilization of required consumables, supporting overall market development across multiple geographic regions.

Technological Platform Advancement

Continuous technological improvements have resulted in more efficient, portable, and accessible NGS platforms. These advancements provide competitive advantages to prominent companies while encouraging research and development initiatives throughout the industry. The introduction of user-friendly systems with enhanced accuracy and speed capabilities has broadened the potential user base and application scenarios.

Market Constraints and Challenges

Skilled Personnel Limitations

The shortage of qualified professionals represents a significant market constraint. The limited availability of skilled personnel capable of interpreting complex NGS data creates bottlenecks in research progress and industry growth. This skills gap particularly affects developing nations where technical expertise may be less readily available, hindering technology adoption and effective utilization.

Research and Development Funding Challenges

Financial constraints in research and development, particularly in developing economies, present ongoing market challenges. Many research institutions and academic organizations face budget limitations that prevent acquisition of advanced, premium-priced NGS equipment and technologies. This funding dependency on external sources creates uncertainty and may limit market expansion in regions with constrained financial resources.

The interpretation of complex data generated by NGS platforms requires specialized expertise and significant time investment, creating operational challenges that may slow research progress and technology adoption rates.

Strategic Implications

The NGS market demonstrates strong growth potential driven by expanding applications, government support, and technological advancement. However, success requires addressing skilled personnel limitations through comprehensive training programs and technology simplification initiatives. Market participants must balance advanced capability development with accessibility considerations to maximize adoption across diverse research environments and geographic regions while supporting the development of local expertise and infrastructure.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2022 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Next Generation Sequencing Market Segments:

By Offerings

Hardware
Software & Services

By Type

Genome Sequencing
Exome Sequencing
Targeted Sequencing

By Method

Sequencing By Synthesis (SBS)
Ion Semiconductor Sequencing
Nanopore Sequencing
Others

By Application

Oncology
Infectious Disease Diagnostics
Drug Discovery & Development
Others

By End-Users

Hospitals & Clinics
Academic & Research Institutes
Pharmaceutical & Biotech Companies
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Taiwan
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NEXT GENERATION SEQUENCING MARKET BY OFFERINGS

5.1. Introduction
5.2. Hardware
5.3. Software & Services

6. NEXT GENERATION SEQUENCING MARKET BY TYPE

6.1. Introduction
6.2. Genome Sequencing
6.3. Exome Sequencing
6.4. Targeted Sequencing

7. NEXT GENERATION SEQUENCING MARKET BY METHOD

7.1. Introduction
7.2. Sequencing By Synthesis (SBS)
7.3. Ion Semiconductor Sequencing
7.4. Nanopore Sequencing
7.5. Others

8. NEXT GENERATION SEQUENCING MARKET BY APPLICATION

8.1. Introduction
8.2. Oncology
8.3. Infectious Disease Diagnostics
8.4. Drug Discovery & Development
8.5. Others

9. NEXT GENERATION SEQUENCING MARKET BY END-USERS

9.1. Introduction
9.2. Hospitals & Clincs
9.3. Academic & Research Institutes
9.4. Pharmaceutical & Biotech Companies
9.5. Others

10. NEXT GENERATION SEQUENCING MARKET BY GEOGRAPHY

10.1. Introduction
10.2. North America
- 10.2.1. USA
- 10.2.2. Canada
- 10.2.3. Mexico
10.3. South America
- 10.3.1. Brazil
- 10.3.2. Argentina
- 10.3.3. Others
10.4. Europe
- 10.4.1. Germany
- 10.4.2. France
- 10.4.3. United Kingdom
- 10.4.4. Spain
- 10.4.5. Others
10.5. Middle East and Africa
- 10.5.1. Saudi Arabia
- 10.5.2. UAE
- 10.5.3. Israel
- 10.5.4. Others
10.6. Asia Pacific
- 10.6.1. China
- 10.6.2. India
- 10.6.3. Japan
- 10.6.4. South Korea
- 10.6.5. Indonesia
- 10.6.6. Thailand
- 10.6.7. Taiwan
- 10.6.8. Others